Effective January 4, 2024, Alzamend Neuro, Inc., a Delaware corporation (the “ Company ”), appointed Milton C. Ault, III as a director and Vice Chairman of its board of directors (the “ Board ”).
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Milton C. Ault, III was appointed as Vice Chairman at Alzamend Neuro, Inc..
Action
appointed
Role
Vice Chairman
Exact text from the filing
Effective January 4, 2024, Alzamend Neuro, Inc., a Delaware corporation (the “ Company ”), appointed Milton C. Ault, III as a director and Vice Chairman of its board of directors (the “ Board ”).
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.